维普期刊资源整合服务平台（V6.5）

维普中文期刊产品整合服务

1篇 您的检索式：作者名="Jenifer R.Prosperi"

选中清除导出查看参考文献查看引证文献引用追踪共1页首页上一页第1页下一页末页 /1 跳转

		题名	作者	年代	出处	被引量
	1	Combating CHK1 resistance in triple negative breast cancer:EGFR inhibition as potential combinational therapy显示文摘Triple negative breast cancer(TNBC)is marked by a lack of expression of the Estrogen Receptor,Progesterone Receptor,and human epidermal growth factor receptor 2.Therefore,targeted therapies are being investigated based on the expression profiles of tumors.Due to the potential for acquired and intrinsic resistance,there is a need for combination therapy to overcome resistance.In the article by Lee et al.,the authors identify that,while prexasertib(a CHK1 inhibitor)lacks efficacy alone,combination with an EGFR inhibitor provides synergistic anti-tumor effects.Advances in targeted therapy for TNBC will benefit the clinical landscape for this disease,with this study initiating a new avenue of investigation.	Casey D.Stefanski Jenifer R.Prosperi	2022	Cancer Drug Resistance2022，5，1：	3

返回顶部每页显示：

共1页首页上一页第1页下一页末页 /1 跳转

goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费